Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Contel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Inorganic Biochemistry|February 12, 2026
NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancerMarayke Mayrata, Alvaro Lopez-Sanchez, Esteban P Urriolabeitia, et al.
Inorganic Chemistry|November 30, 2021
Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse ModelKirill Miachin, Virginia Del Solar, Elsy El Khoury, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model"Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science|December 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse ModelAfruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
FEMS Microbiology Letters|June 10, 2016
Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pyloriJoshua P Owings, Nina N McNair, Yiu Fung Mui, et al.
ACS Pharmacology & Translational Science|May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium CompoundNazia Nayeem, Sami Sauma, Afruja Ahad, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Inorganic Biochemistry|February 12, 2026
NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancerMarayke Mayrata, Alvaro Lopez-Sanchez, Esteban P Urriolabeitia, et al.
Inorganic Chemistry|November 30, 2021
Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse ModelKirill Miachin, Virginia Del Solar, Elsy El Khoury, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model"Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science|December 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse ModelAfruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
FEMS Microbiology Letters|June 10, 2016
Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pyloriJoshua P Owings, Nina N McNair, Yiu Fung Mui, et al.
ACS Pharmacology & Translational Science|May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium CompoundNazia Nayeem, Sami Sauma, Afruja Ahad, et al.
Pageof 3